Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad W Saif

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Annals of Saudi Medicine|August 25, 2009
Management of ascites due to gastrointestinal malignancyMuhammad W Saif, Imran A P Siddiqui, Muhammad A Sohail
Cureus|August 25, 2016
Small Bowel Neuroendocrine Tumors with Inguinal Metastases: A Diagnostic and Therapeutic DilemmaFaisal Inayat, Kevin P Daly, Farhad Askarian, et al.
The Clinical Respiratory Journal|December 19, 2013
Epidemiology of active tuberculosis in lung cancer patients: a systematic reviewAntonis Christopoulos, Muhammad W Saif, Evangelos G Sarris, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 19, 2020
Hyperpigmentation due to imatinib: A rare case of cutaneous involvementHasan Rehman, Nausheen Hakim, Ryan Sugarman, et al.
Springerplus|March 18, 2014
Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a reviewCharalampos Gkogkou, Konstantina Frangia, Muhammad W Saif, et al.
Cancer Treatment Reviews|November 19, 2013
Multimodal treatment strategies for elderly patients with head and neck cancerEvangelos G Sarris, Kevin J Harrington, Muhammad W Saif, et al.
Cureus|August 6, 2016
Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?Muhammad W Saif, Archana Agarwal, James Hellinger, et al.
JOP : Journal of the Pancreas|July 17, 2012
Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress?Vassilios S Ramfidis, Alexios S Strimpakos, Kostas N Syrigos, et al.
Pancreas (Fairfax, Va.)|February 8, 2020
PARP Inhibitors in Pancreatic Cancer: From Phase I to Plenary SessionRajvi Patel, Daniel Fein, Carolina B Ramirez, et al.
Anti-Cancer Drugs|April 4, 2009
Hypersensitivity reactions to antineoplastic agents: an overviewEkaterini Syrigou, Nektaria Makrilia, Ioanna Koti, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Annals of Saudi Medicine|August 25, 2009
Management of ascites due to gastrointestinal malignancyMuhammad W Saif, Imran A P Siddiqui, Muhammad A Sohail
Cureus|August 25, 2016
Small Bowel Neuroendocrine Tumors with Inguinal Metastases: A Diagnostic and Therapeutic DilemmaFaisal Inayat, Kevin P Daly, Farhad Askarian, et al.
The Clinical Respiratory Journal|December 19, 2013
Epidemiology of active tuberculosis in lung cancer patients: a systematic reviewAntonis Christopoulos, Muhammad W Saif, Evangelos G Sarris, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 19, 2020
Hyperpigmentation due to imatinib: A rare case of cutaneous involvementHasan Rehman, Nausheen Hakim, Ryan Sugarman, et al.
Springerplus|March 18, 2014
Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a reviewCharalampos Gkogkou, Konstantina Frangia, Muhammad W Saif, et al.
Cancer Treatment Reviews|November 19, 2013
Multimodal treatment strategies for elderly patients with head and neck cancerEvangelos G Sarris, Kevin J Harrington, Muhammad W Saif, et al.
Cureus|August 6, 2016
Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?Muhammad W Saif, Archana Agarwal, James Hellinger, et al.
JOP : Journal of the Pancreas|July 17, 2012
Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress?Vassilios S Ramfidis, Alexios S Strimpakos, Kostas N Syrigos, et al.
Pancreas (Fairfax, Va.)|February 8, 2020
PARP Inhibitors in Pancreatic Cancer: From Phase I to Plenary SessionRajvi Patel, Daniel Fein, Carolina B Ramirez, et al.
Anti-Cancer Drugs|April 4, 2009
Hypersensitivity reactions to antineoplastic agents: an overviewEkaterini Syrigou, Nektaria Makrilia, Ioanna Koti, et al.
Pageof 8